An observational study in Cardiac Output, Low, sponsored by Sharp HealthCare. Completed at 1 site in United States. Open to participants aged Up to 1 Minute. Per ClinicalTrials.gov, last updated 2015-05-20.
Sponsored by Sharp HealthCare · Observational
Recently, the American College of Obstetricians and Gynecologists (ACOG) recommended a delay of 30-60 seconds in umbilical cord clamping for all newborn infants. This delay allows the newborn to receive his/her own blood from the placenta (placental transfusion) which helps their transition in the first hours of life. The purpose of the study is to learn about the amount of blood flow to and from the baby's heart during normal newborn transition
94 studies on the registry are indexed under Cardiac Output, Low; 15 are open to participants now.
This study's enrollment of 20 is below the median of 60 across 45 observational studies indexed under Cardiac Output, Low.
Browse Cardiac Output, Low studies →Sharp HealthCare is the lead sponsor of 40 studies on the registry; 4 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Healthy full term infants delivered by vaginal birth with an estimated gestational age of 37+1 to 41+6 weeks corrected gestational age
Exclusion Criteria:
Cardiac Output
Time frame: 5 minutes of Life
Stroke Volume
Time frame: 5 Minutes of Life
Bilirubin level
Time frame: until discharge
Hemoglobin level
Time frame: until discharge
This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sharp HealthCare